🇺🇸 FDA
Pipeline program

FF/UMEC/VI

ROB0046

Phase 3 small_molecule active

Quick answer

FF/UMEC/VI for Asthma is a Phase 3 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Grace Therapeutics
Indication
Asthma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials